"Mother Goose: Journey To Utopia" Synopsis, Information
" Mother Goose: Journey To Utopia " Synopsis, Information Page
Tentative Principle Photography: Begin by April 30, 2016.
Studios: Hannover House (Theatrical), 20th Century Fox (Home Video)
Tentative Cast: Shirley MacLaine, Samuel Jackson
Synopsis: Family-Appeal "Fantasy" Adventures films rank among the highest grossing movies of all time. Bridging the commercial markets for both kids and adults, fantasy adventures have an evergreen value and a worldwide appeal, "Mother Goose: Journey To Utopia" builds on the awareness and characters from the infamous "Mother Goose" fables, and combines it with the audience-friendly element of "transportation to a magical world." The result is a pleasing and commercial adventure that is ideally positioned to become an entertaining and popular movie experience. With major star casting - including Academy Award Winner SHIRLEY MACLAINE as "Mother Goose" and SAMUEL JACKSON as "Valkerna" - this film could achieve the stature of other, comparably themed films, including "Chronicles of Narnia", "Tim Burton's Alice In Wonderland" and the recently released "Oz: The Great and Powerful."
"Mother Goose: Journey To Utopia" tells the story of young Jack and Gillian, two pre-teen kids from modern-day America. In researching a homework assignment, they stumble upon a mysterious and dusty old book of Mother Goose rhymes. Upon opening the book, they are pulled from their world and thrust in to the magical - and fantastical - land of Utopia and Mother Goose. Here they are faced with the challenge of saving Mother Goose from an evil villain, Valkerna, who believes that children no longer have any imagination. As Jack and Gillian proceed on their journey, they run into a variety of amusing and enchanted characters who provide various forms of advice and assistance to help them save Mother Goose. In the end, though, it is the imaginations of Jack and Gillian to save the day, and return them to their own world.
http://hannoverhousemovies.blogspot.com/2013/...ey-to.html
March 10, 2016 b). Financing Agreement for "Mother Goose: Journey To Utopia" - Hannover House was offered the opportunity to move immediately on the funding of this major "event-level" project, but only if we were able to commence principal photography on or before April 30, 2016. The structure of the Mother Goose funding extends beyond the production costs, and includes a mechanism for $10-mm in P&A to support a theatrical release launch onto approximately 1,785 screens. This is such a significant, material level development for the Company that it requires an immediate refocus of management resources and support staffing. Principal photography will occur primarily in the State of Georgia, with certain scenes shot in Ireland (castles / epic sequences), under a EU Certified Co-Production venture. HHSE plans to comply with the April 30 launch date requirement, and expects to have a major announcement (and "promo reel"
on display at the Company's booth at the Cannes Film Festival / Marche Du Filme in May.
http://hannoverhousemovies.blogspot.com/2016/...onics.html
5/8/12: Shirley MacLaine In ‘Mother Goose’ Talks:
http://deadline.com/2012/05/shirley-maclaine-...ks-268719/
1
Hannover House Inc. (HHSE) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Top 5 Most Recently Viewed Articles
Exro Technologies Reports First Quarter Results Exro Technologies Inc. (TSX: EXRO), a prominent tech company specializing in power control solutions for electric vehicles and energy storage, has recently announced its financial results for the first quarter of the year. This highlights their ongoing transition from technology validation towards commercial operations and...
Continue Reading
dsm-firmenich Welcomes New Executive Committee Members dsm-firmenich is set to usher in a transformative era by strengthening its Executive Committee, as it embarks on a journey to intensify its consumer-centered approach. This restructuring aims to solidify its standing as a top-tier partner in creation and innovation across the nutrition, health, and beauty sectors. The...
Continue Reading
Insight Partners Launches New Funds to Propel Software Innovation Global software investor, Insight Partners, has recently celebrated a significant milestone by announcing the closing of its thirteenth flagship fund alongside a dedicated buyout co-invest fund, collectively known as "Fund XIII". This announcement is particularly special as it coincides with the firm's 30th...
Continue Reading
Acumatica's AI Innovations Transform Business Operations During an inspiring keynote at a recent summit, Acumatica showcased its commitment to revolutionizing business operations with an AI-first product strategy. This innovative approach aims to significantly enhance how small and mid-sized businesses operate, addressing the real-world challenges they face. With advanced...
Continue Reading
The Expanding Microbiological Testing of Water Market As the demand for clean and safe water continues to surge, the global microbiological testing of water market is set to experience significant growth, reaching an impressive $2.3 billion by 2027, with a robust compound annual growth rate (CAGR) of 7.4%. The rising consciousness among consumers regarding the importance...
Continue Reading